<DOC>
	<DOCNO>NCT00260988</DOCNO>
	<brief_summary>The purpose study well understand either dalteparin tinzaparin well drug use dialysis patient blood thinner high risk develop blood clot need surgery .</brief_summary>
	<brief_title>A Comparison Dalteparin Tinzaparin Prevention Blood Clots Hemodialysis Patients Oral Anticoagulants Having Surgery</brief_title>
	<detailed_description>A prospective multicenter randomise trial involve 60 consecutive eligible consenting patient teach hospital Canada . Patients randomise either tinzaparin dalteparin investigate pharmacokinetics low molecular weight heparin ( LMWH ) perioperatively special population , namely end stage renal disease ( ESRD ) dialysis patient . To date although exists evidence suggest tinzaparin may safe patient hemodialysis , LMWHs group investigate perioperative setting patient . This protocol develop pharmacokinetic behaviour tinzaparin dalteparin compare also duration warfarin minimise . Therapeutic dos LMWH administer pre-procedure much time period possible oral anticoagulation sub-therapeutic .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Tinzaparin</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>Informed consent Patients age &gt; = 18 end stage renal disease require chronic hemodialysis ( HD ) three time week clinically stable HD 4 week ( x 4 wks ) Patients require active oral anticoagulation prosthetic heart valve , recent deep vein thrombosis &gt; = 1 month , patient atrial fibrillation major risk factor ( previous transient ischemic attack [ TIA ] stroke , high blood pressure , diabetes , age &gt; = 75 , moderate/severe leave ventricle dysfunction ) require elective noncardiac surgery invasive procedure reversal anticoagulant therapy . Evidence active bleeding prior stop warfarin Hemoglobin &lt; = 90 platelet count &lt; = 100x10^9/L Uncontrolled hypertension stroke within 6 month study commencement Spinal neurosurgery Eye surgery ( exclude cataract surgery ) Life expectancy le 3 month Patients require cardiac surgery Presence active duodenal ulcer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Prophylaxis</keyword>
	<keyword>Thromboembolic disease</keyword>
	<keyword>End stage renal disease</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Low Molecular Weight Heparin</keyword>
	<keyword>Innohep</keyword>
	<keyword>Tinzaparin</keyword>
	<keyword>Fragmin</keyword>
	<keyword>Dalteparin</keyword>
	<keyword>Anti Xa</keyword>
	<keyword>INR</keyword>
	<keyword>Oral anticoagulation</keyword>
	<keyword>warfarin</keyword>
	<keyword>Coumadin</keyword>
</DOC>